FDA Approved: MONTELUKAST — Supplemental Application (XLCare Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Montelukast from XLCare Pharmaceuticals Inc., approving changes to the generic product under an ANDA. This repre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma
• Exercise-induced Bronchoconstriction

Drugs mentioned

• Montelukast (Montelukast)
• Montelukast Sodium (Montelukast Sodium)

Snippet

SUPPL AP for MONTELUKAST (MONTELUKAST)